Status:
RECRUITING
Cardio-Renal Registry
Lead Sponsor:
Queen Mary University of London
Conditions:
End Stage Renal Disease
Cardio-Renal Syndrome
Eligibility:
All Genders
16+ years
Brief Summary
Cardiovascular disease is the leading cause of morbidity and mortality among patients with chronic kidney disease (CKD). Even after adjustment for known cardiovascular risk factors, including diabetes...
Eligibility Criteria
Inclusion
- Informed consent will not be sought for, as patients are automatically included onto a database that we will use for research purposes. No children will be included in this study. Vulnerable adults or those unable to give consent will be included in the study as well if they are referred to the Nephrology team.
- Both male and female patients ≥16 years of age will be included
- All patients will be reviewed by the Nephrology team a the RLH with renal disease.
Exclusion
- 1\. Patients \<16 years will not be included in this study.
Key Trial Info
Start Date :
August 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2030
Estimated Enrollment :
60000 Patients enrolled
Trial Details
Trial ID
NCT06521801
Start Date
August 1 2024
End Date
June 1 2030
Last Update
January 7 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barts Health NHS Trust
London, United Kingdom, EC1A 7BE